Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis

Michael F. Goy (Inventor), Nicholas G. Moss (Inventor), Xun Qian (Inventor)

Research output: Patent

Abstract

A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized by salt retention, fluid retention, salt loss, fluid loss, and combinations thereof. An immunoassay kit for detecting a level of prouroguanylin in a sample.
LanguageEnglish
Patent number8173596
IPCA61K 38/00 (20060101); A61P 7/10 (20060101); A61P 9/00 (20060101); A61P 9/12 (20060101)
StatePublished - 1800

Fingerprint

Homeostasis
Salts
Immunoassay
Therapeutics
prouroguanylin

Cite this

Goy, M. F., Moss, N. G., & Qian, X. (1800). IPC No. A61K 38/00 (20060101); A61P 7/10 (20060101); A61P 9/00 (20060101); A61P 9/12 (20060101). Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis (Patent No. 8173596.)

Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis. / Goy, Michael F. (Inventor); Moss, Nicholas G. (Inventor); Qian, Xun (Inventor).

IPC No.: A61K 38/00 (20060101); A61P 7/10 (20060101); A61P 9/00 (20060101); A61P 9/12 (20060101). Patent No.: 8173596.

Research output: Patent

Goy, MF, Moss, NG & Qian, X 1800, Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis, Patent No. 8173596, IPC No. A61K 38/00 (20060101); A61P 7/10 (20060101); A61P 9/00 (20060101); A61P 9/12 (20060101).
Goy MF, Moss NG, Qian X, inventors. Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis. A61K 38/00 (20060101); A61P 7/10 (20060101); A61P 9/00 (20060101); A61P 9/12 (20060101). 1800
Goy, Michael F. (Inventor) ; Moss, Nicholas G. (Inventor) ; Qian, Xun (Inventor). / Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis. IPC No.: A61K 38/00 (20060101); A61P 7/10 (20060101); A61P 9/00 (20060101); A61P 9/12 (20060101). Patent No.: 8173596.
@misc{dfcff20aab1644878d3038d29baca0ec,
title = "Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis",
abstract = "A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized by salt retention, fluid retention, salt loss, fluid loss, and combinations thereof. An immunoassay kit for detecting a level of prouroguanylin in a sample.",
author = "Goy, {Michael F.} and Moss, {Nicholas G.} and Xun Qian",
note = "Status: published applicationnumber: 11/596,493 usclass: 514/12.4 ; 514/15.6; 514/15.7; 514/16.4; 514/869 applicationnumber: 11/596,493; 8173596; A61K 38/00 (20060101); A61P 7/10 (20060101); A61P 9/00 (20060101); A61P 9/12 (20060101)",
year = "1800",
language = "English",
type = "Patent",

}

TY - PAT

T1 - Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from it, as Therapeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis

AU - Goy,Michael F.

AU - Moss,Nicholas G.

AU - Qian,Xun

N1 - Status: published applicationnumber: 11/596,493 usclass: 514/12.4 ; 514/15.6; 514/15.7; 514/16.4; 514/869 applicationnumber: 11/596,493

PY - 1800

Y1 - 1800

N2 - A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized by salt retention, fluid retention, salt loss, fluid loss, and combinations thereof. An immunoassay kit for detecting a level of prouroguanylin in a sample.

AB - A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized by salt retention, fluid retention, salt loss, fluid loss, and combinations thereof. An immunoassay kit for detecting a level of prouroguanylin in a sample.

M3 - Patent

M1 - 8173596

ER -